Income Taxes (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Income Taxes (Details) [Line Items] | ||||
| Valuation allowance | $ 83,153 | |||
| Valuation allowance increase (decrease) | $ 22,800,000 | $ 17,100 | ||
| Deferred tax liability | 28,400 | |||
| Offsetting increase decrease to valuation allowance | 11,300 | |||
| Operating loss carryforwards | $ 703,800 | $ 517,700 | ||
| Operating loss carryforwards, description | U.S. federal net operating loss carryforwards begin to expire in 2033, and state operating loss carryforwards begin to expire in 2027. | |||
| Forecast [Member] | ||||
| Income Taxes (Details) [Line Items] | ||||
| Federal research and development credit carryforwards for income tax expense | $ 1,200 | |||
| U.S. Federal [Member] | ||||
| Income Taxes (Details) [Line Items] | ||||
| Net operating losses | $ 341,300 | |||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of offsetting increase (decrease) to valuation allowance. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from frequent flier obligations. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of the valuation allowance recorded in a business combination against deductible temporary differences for which related tax benefits will be recorded as a reduction of the acquired entity's goodwill and other noncurrent intangible assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|